Natural killer cells as effectors of selection and differentiation of stem cells: Role in resolution of inflammation

References

• Abdulkarim, B., Sabri, S., Deutsch, E., et al. 2002. Anti-viral agent Cidofovir restores p53 function and enhances radiosensitivity in HPV-associated cancers. Oncogene 21:2334–2346
   PubMed Web of Science ®Google Scholar
• Azzoni, L., Anegon, I., Calabretta, B., and Perussia, B. 1995. Ligand binding to FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154:491–499
   PubMed Web of Science ®Google Scholar
• Berlin, A. L., Paller, A. S., and Chan, L. S. 2002. Incontinentia pigmenti: A review and update on molecular basis of pathophysiology. J. Am. Acad. Dermatol. 47:169–187
   PubMed Web of Science ®Google Scholar
• Bonavida, B., Lebow, L. T., and Jewett, A. 1993. Natural killer cell subsets: Maturation, differentiation and regulation. Nat. Immunol. 12:194–208
   Google Scholar
• Chatenoud, L. 2003. CD3-specific antibody-induced active tolerance: From bench to bedside. Nat. Rev. Immunol. 3:123–132
   PubMed Web of Science ®Google Scholar
• Coffelt, S. B., Hughes, R., and Lewis, C. E. 2009. Tumor-associated macrophages: Effectors of angiogenesis and tumor progression. Biochim. Biophys. Acta. 1796:11–18
   PubMed Web of Science ®Google Scholar
• Cooper, M. A., Fehniger, T. A., and Caligiuri, M. A. 2001. The biology of human NK cell subsets. Trends Immunol. 22:633–640
   PubMed Web of Science ®Google Scholar
• Deer, E. L., Gonzalez-Hernandez, J., Coursen, J. D., et al. 2010. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 39:425–435
   Google Scholar
• Dunn, G. P., Bruce, A. T., Ikeda, H., et al. 2002. Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol. 3:991–998
   PubMed Web of Science ®Google Scholar
• Dunn, G. P., Old, L. J., and Schreiber, R. D. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148
   PubMed Web of Science ®Google Scholar
• Farag, S. S., and Caligiuri, M. A. 2006. Human natural killer cell development and biology. Blood Rev. 20:123–137
   PubMed Web of Science ®Google Scholar
• Fildes, J. E., Yonan, N., and Leonard, C. T. 2008. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance. Transplant. Immunol. 19:1–11
   PubMed Web of Science ®Google Scholar
• Greten, T. F., Manns, M. P., and Korangy, F. 2011. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11:802–807
   PubMed Web of Science ®Google Scholar
• Hu, P. F., Hultin, L. E., Hultin, P., et al. 1995. Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56− cells with low lytic activity. J. AIDS Human Retrovirol. 10:331–340
   Google Scholar
• Inagaki, A., Soeda, A., Oka, N., et al. 2007. Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions. Biochem. Biophys. Res. Commun. 361:586–592
   PubMed Web of Science ®Google Scholar
• Jewett, A., and Bonavida, B. 1994. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNFα and IFNγ secretion. Cell. Immunol. 154:273–286
   PubMed Web of Science ®Google Scholar
• Jewett, A., and Bonavida, B. 1995. Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset. Cell. Immunol. 160:91–97
   PubMed Web of Science ®Google Scholar
• Jewett, A., and Bonavida, B. 1996. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J. Immunol. 156:907–915
   PubMed Web of Science ®Google Scholar
• Jewett, A., and Bonavida, B. 2000. MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: Role of endogenously-secreted TNFα. Clin. Immunol. 96:19–28
   PubMed Web of Science ®Google Scholar
• Jewett, A., and Tseng H. C. 2013. Tumor microenvironment may shape the function and phenotype of NK cells through theinduction of split anergy and generation of regulatory NK cells. In: The Tumor Immunoenvironment. (Shurin, M., Umansky, V., and Malyguine, A., Eds.). Basel: Springer, pp. 361–384
   Google Scholar
• Jewett, A., Arasteh, A., Tseng, H. C., et al. 2010. Strategies to rescue mesenchymal stem cells (MSC) and dental pulp stem cells (DPSC) from NK cell-mediated cytotoxicity. PLoS One 5:e9874
   PubMed Web of Science ®Google Scholar
• Jewett, A., Cacalano, N. A., Head, C., and Teruel, A. 2006a. Co-engagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells. Clin. Cancer Res. 12:1994–2003
   PubMed Web of Science ®Google Scholar
• Jewett, A., Cacalano, N. A., Teruel, A., et al. 2006b. Inhibition of NF-κB activity in oral tumor cells prevents depletion of NK cells and increases their functional activation. Cancer Immunol. Immunother. 55:1052–1063
   PubMed Web of Science ®Google Scholar
• Jewett, A., Cavalcanti, M., and Bonavida, B. 1997. Pivotal role of endogenous TNFα in the induction of functional inactivation and apoptosis in NK cells. J. Immunol. 159:4815–4822
   PubMed Web of Science ®Google Scholar
• Jewett, A., Gan, X. H., Lebow, L. T., and Bonavida, B. 1996. Differential secretion of TNFα and IFNγ by human peripheral blood-derived NK subsets and association with functional maturation. J. Clin. Immunol. 16:46–54
   PubMed Web of Science ®Google Scholar
• Jewett, A., Head, C., and Cacalano, N. A. 2006c. Emerging mechanisms of immunosuppression in oral cancers. J. Dent. Res. 85:1061–1073
   PubMed Web of Science ®Google Scholar
• Jewett, A., Man, Y. G., and Tseng, H. C. 2013. Dual functions of NK cells in selection and differentiation of stem cells: Role in regulation of inflammation and regeneration of tissues. J. Cancer 4:12–24
   PubMed Web of Science ®Google Scholar
• Jewett, A., Teruel, A., Romero, M., et al. 2008. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody. Cancer Immunol. Immunother. 57:1053–1066
   PubMed Web of Science ®Google Scholar
• Jewett, A., Wang, M. Y., Teruel, A., et al. 2003. Cytokine dependent inverse regulation of CD54 (ICAM1) and major histocompatibility complex Class I antigens by NF-κB in HEp2 tumor cell line: Effect on the function of NK cells. Human Immunol. 64:505–520
   PubMed Web of Science ®Google Scholar
• Jiang, B., Mason, J., Jewett, A., et al. 2013a. Tumor-infiltrating immune cells: Triggers for tumor capsule disruption and tumor progression? Int. J. Med. Sci. 10:475–497
   PubMed Web of Science ®Google Scholar
• Jiang, B., Mason, J., Jewett, A., et al. 2013b. Cell budding from normal appearing epithelia: Predictor of colorectal cancer metastasis? Int. J. Biol. Sci. 9:119–133
   PubMed Web of Science ®Google Scholar
• Kuss, I., Saito, T., Johnson, J. T., and Whiteside, T. L. 1999. Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin. Cancer Res. 5:329–334
   PubMed Web of Science ®Google Scholar
• Lai, P., Rabinowich, H., Crowley-Nowick, P. A., et al. 1996. Alterations in expression and function of signal-transducing proteins in tumor-associated T and NK cells in patients with ovarian carcinoma. Clin. Cancer Res. 2:161–173
   PubMed Web of Science ®Google Scholar
• Man, Y. G., Stojadinovic, A., Mason, J., et al. 2013. Tumor-infiltrating immune cells promoting tumor invasion and metastasis: Existing theories. J. Cancer 4:84–95
   PubMed Web of Science ®Google Scholar
• Mandelboim, O., Malik, P., Davis, D. M., et al. 1999. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc. Natl. Acad. Sci. USA 96:5640–5644
   PubMed Web of Science ®Google Scholar
• Mantovani, A., and Sica, A. 2010. Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Curr. Opin. Immunol. 22:231–237
   PubMed Web of Science ®Google Scholar
• Marigo, I., Dolcetti, L., Serafini, P., et al. 2008. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222:162–179
   PubMed Web of Science ®Google Scholar
• Murakami, J., Asaumi, J., Kawai, N., et al. 2005. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. Cancer Chemother. Pharmacol. 56:22–28
   PubMed Web of Science ®Google Scholar
• Murakami, J., Asaumi, J., Maki, Y., et al. 2004. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines. Oncol. Rep. 12:339–345
   PubMed Web of Science ®Google Scholar
• Nemeth, E., Baird, A. W., and O'Farrelly, C. 2009. Microanatomy of the liver immune system. Semin. Immunopathol. 31:333–343
   PubMed Web of Science ®Google Scholar
• Oka, N., Soeda, A., Inagaki, A., et al. 2007. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem. Biophys. Res. Commun. 360:553–559
   PubMed Web of Science ®Google Scholar
• Ortaldo, J. R., Mason, A. T., and O'Shea, J. J. 1995. Receptor-induced death in human natural killer cells: Involvement of CD16. J. Exp. Med. 181:339–344
   PubMed Web of Science ®Google Scholar
• Pasparakis, M., Courtois, G., Hafner, M., et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of Iκκ2. Nature 417:861–866
   PubMed Web of Science ®Google Scholar
• Patankar, M. S., Yu, J., Morrison, J. C., et al. 2005. Potent suppression of NK cell response mediated by the ovarian tumor marker CA125. Gynecol. Oncol. 99:704–713
   PubMed Web of Science ®Google Scholar
• Pegram, H. J., Andrews, D. M., Smyth, M. J., et al. 2011. Activating and inhibitory receptors of NK cells. Immunol. Cell. Biol. 89:216–224
   PubMed Web of Science ®Google Scholar
• Rahaman, S. O., Harbor, P. C., Chernova, O., et al. 2002. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21:8404–8413
   PubMed Web of Science ®Google Scholar
• Romagnani, C., Juelke, K., Falco, M., et al. 2007. CD56brightCD16– killer Ig-like receptor NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178:4947–4955
   PubMed Web of Science ®Google Scholar
• Seitz, C. S., Lin, Q., Deng, H., and Khavari, P. A. 1998. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. USA 95:2307–2312
   PubMed Web of Science ®Google Scholar
• Sipos, B., Moser, S., Kalthoff, H., et al. 2003. A comprehensive characterization of pancreatic ductal carcinoma cell lines: Towards the establishment of an in vitro research platform. Virchows Arch. 442:444–452
   Google Scholar
• Soeda, A., Inagaki, A., Oka, N., et al. 2008. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J. Biol. Chem. 283:10958–10966
   PubMedGoogle Scholar
• Squier, C. A., and Kremer, M. J. 2001. Biology of oral mucosa and esophagus. J. Natl. Cancer Inst. Monogr. 29:7–15
   PubMedGoogle Scholar
• Strowig, T., Chijioke, O., Carrega, P., et al. 2010. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116:4158–4167
   PubMed Web of Science ®Google Scholar
• Tseng, H. C., Arasteh, A., Paranjpe, A., et al. 2010. Increased lysis of stem cells but not their differentiated cells by NK cells: De-differentiation or reprogramming activates NK cells. PLoS One 5:e11590
   PubMed Web of Science ®Google Scholar
• van Hogerlinden, M., Rozell, B. L., Ahrlund-Richter, L., and Toftgard, R. 1999. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/NF-κB signaling. Cancer Res. 59:3299–3303
   PubMed Web of Science ®Google Scholar
• van Hogerlinden, M., Rozell, B. L., Toftgard, R., and Sundberg, J. P. 2004. Characterization of the progressive skin disease and inflammatory cell infiltrate in mice with inhibited NF-κB signaling. J. Invest. Dermatol. 123:101–108
   PubMed Web of Science ®Google Scholar
• Vuk-Pavlovic, S. 2008. Rebuilding immunity in cancer patients. Blood Cells Mol. Dis. 40:94–100
   PubMed Web of Science ®Google Scholar
• Wang, T., G. Niu, G., Kortylewski, M., et al. 2004. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10:48–54
   Google Scholar
• Yaguchi, T., Sumimoto, H., Kudo-Saito, C., et al. 2011. Mechanisms of cancer immunoescape and development of overcoming strategies. Int. J. Hematol. 93:294–300
   PubMed Web of Science ®Google Scholar
• Yu, J., W. Du, W., Yan, F., et al. 2013. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J. Immunol. 190:3783–3797
   Google Scholar